← Back to Search

Lyopreserved Stravix for Diabetic Wounds

Phase 4

Waitlist Available

Led By Lawrence Lavery, DPM MPH

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial will compare two methods of wound healing to see which is more effective.

Eligible Conditions

Diabetic Wounds

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Complete Wound Closure

Secondary outcome measures

Duration of Negative Pressure Wound Therapy

Infection

Split Thickness Skin Grafting

Trial Design

2Treatment groups

Active Control

Group I: Lyopreserved StravixActive Control1 Intervention

Treated with NPWT and lyopreserved Stravix

Group II: Cryopreserved StravixActive Control1 Intervention

Treated with NPWT and cryopreserved Stravix

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,047 Previous Clinical Trials

1,053,753 Total Patients Enrolled

1 Trials studying Diabetic Wounds

Osiris TherapeuticsIndustry Sponsor

8 Previous Clinical Trials

572 Total Patients Enrolled

Lawrence Lavery, DPM MPHPrincipal InvestigatorUT Southwestern Medical Center

7 Previous Clinical Trials

3,314 Total Patients Enrolled

1 Trials studying Diabetic Wounds

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this investigation available to participants as of now?

"As indicated on clinicaltrials.gov, this medical trial is presently looking for participants. The experiment was initially posted on June 22nd 2021 and edited most recently on July 18th 2022."

Answered by AI

Has Cryopreserved Stravix been granted authorization by the FDA?

"Previous clinical data has validated the safety of Cryopreserved Stravix, resulting in an overall score of 3."

Answered by AI

To what extent are individuals being monitored in this clinical research?

"Affirmative, the clinical trial is open for enrolment. It was first posted on June 22nd 2021 and most recently amended on July 18th 2022. The study aims to assess forty patients through a solitary testing site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds

Larry Lavery 2021. "Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04405765.